The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Wednesday. In afternoon trade, the benchmark index is up 0.75% to 8,966.3 points.
Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:
Bank of Queensland Ltd (ASX: BOQ)
The Bank of Queensland share price is up almost 2% to $7.25. This follows the release of the regional bank's full year results this morning. Bank of Queensland reported a 12% increase in cash earnings to $383 million for the 12 months. This was driven by improved margins, good cost control, and growth in commercial lending. This allowed the Bank of Queensland board to increase its fully franked final dividend by approximately 18% to 20 cents per share, which took its total dividends for FY 2025 to 38 cents per share.
Jumbo Interactive Ltd (ASX: JIN)
The Jumbo Interactive share price is up 9.5% to $10.73. Investors have been buying this online lottery ticket seller's shares after it announced a major acquisition. Jumbo has agreed to pay a total of $110 million to acquire UK-based Dream Car Giveaways. It is a leading business-to-consumer (B2C) brand and digital market proposition in the UK prize draw market. It allows customers to win prizes, such as cars, cash, property, and lifestyle products. Jumbo's CEO, Mike Veverka said: "Jumbo's two decades of B2C success in Australia and its world-class software, marketing, and customer management expertise, provides DCG with the foundation to continue its already impressive growth."
Santana Minerals Ltd (ASX: SMI)
The Santana Minerals share price is up over 4% to 86 cents. This has been driven by the release of assay results from the gold developer's ongoing drilling programme at RAS North. Management notes that the results continue to demonstrate strong grade continuity within the HG1 domain. It said: "Recent results from the RINA (RAS-is-Not-Alone) sterilisation drill programme provide further information on the Rise and Shine Shear Zone (RSSZ), confirming it as a fertile, camp-scale gold system that remains largely untested outside the known deposits."
Telix Pharmaceuticals Ltd (ASX: TLX)
The Telix Pharmaceuticals share price is up 14% to $16.37. Investors have been buying the radiopharmaceuticals company's shares following the release of its third quarter update. Telix reported a 53% jump in revenue to US$206 million for the three months. This appears to have been stronger than management was expecting, which has led to it lifting its guidance for the full year. Telix is now expecting revenue of US$800 million to US$820 million. This compares to its previous guidance range of US$770 million to US$800 million. Telix CEO, Dr Christian Behrenbruch, said: "We believe this is a solid result, particularly in light of the reimbursement dynamics during the quarter. Moreover, a 3% increase in dose volumes suggests competitive pricing pressures are beginning to stabilize."
